慢性肾衰竭继发性甲状旁腺功能亢进的诊治现状
被引量:5
摘要
继发性甲状旁腺功能亢进(SHPT)是慢性肾衰竭(CRF)的常见并发症之一,当内生肌酐清除率(Ccr)〈70 mL/min时即可有甲状旁腺激素(PTH)增高,
出处
《现代中西医结合杂志》
CAS
2011年第15期1936-1938,共3页
Modern Journal of Integrated Traditional Chinese and Western Medicine
参考文献19
-
1张训.慢性肾脏病继发性甲状旁腺功能亢进的新认识[J].中国中西医结合肾病杂志,2010,11(4):283-285. 被引量:15
-
2Ketteler M,Biggar PH.AS nature did not dialysis--what we can learn from FGF-23 in end-stage renal diease?[J].Nephrol Dialtransplant,2009,24(9):2618-2620.
-
3Kazama JJ,Sato F,Omori K,et al.Pretreatment serum FGF-23[J].Levey Int,2005,67:1120-1125.
-
4Arcidiacono M,Sato T,Alvarez-Hernandez D.EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease[J].J Am Soc Nephrol,2008,19(2):310-320.
-
5姚泰.生理学[M].6版.北京:人民卫生出版社,2003:209.
-
6刘红.慢性肾衰继发性甲状旁腺功能亢进的治疗进展[J].肾脏病与透析肾移植杂志,2001,10(3):257-260. 被引量:18
-
7张波,杨红,范文奎,招敏仪.阿法骨化醇胶丸联合碳酸钙片治疗慢性肾衰继发甲状旁腺功能亢进的疗效观察[J].中国药房,2005,16(14):1086-1088. 被引量:4
-
8Ohtsuka N,Urayama K.Pharmacological action and clinical effects of falecalcitriol,a highly potent derivative of active vitamam D3[J].Nippon Yakurigaku Zasshi,2002,120(6):4271.
-
9郭云珊,袁伟杰,刘明媛,崔若兰.1,25(OH)_2D_3抑制甲状旁腺激素对维持性血液透析患者残余肾功能的影响[J].中国血液净化,2005,4(8):420-423. 被引量:7
-
10Messa P,Macario F,Yaqoop M,et al.The OPTIMA study:assessing a new cinacalect(Sensipar/Mimpara) treatment algorithm for sencondary hyperparathyroidism[J].Clin J Am Soc Nephrol,2008,3(1):36-45.
二级参考文献66
-
1Wetmore JB,Quades LD.Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease:time for a paradigm shift? Nat Clin Pract Nephrol,2009,5:24-33.
-
2Liu S,Quarles LD.How fibroblast growth factor 23 works.J Am Soc Nephrol,2007,18(6):1637-1647.
-
3Kuro-o M.Klotho in chronic kidney disease--what' s new?Nephrol Dial Transplant,2009,24(6):1705-1708.
-
4Ketteler M,Biggar PH.As nature did not predict dialysis-what we can learn from FGF23 in end-stage renal disease? Nephrol Dial Transplant,2009,24(9):2618-2620.
-
5Martin KI,Goldfarb S.Renal bone disease,disorders of divalent ions and nephrolithiasis NephSAP,2008,7:304-317.
-
6Valle C,Rodriguez M,Santarnaria R,et al.Cinacalcet reduces the set point of the PTH-calcium curve.J Am Soc Nephrol,2008,19(12):2430-2436.
-
7Messa P,Macário F,Yaqoob M,et al.The OPTIMA study:assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism.Clin J Am Soc Nephrol,2008,3(1):36-45.
-
8Fishbane S,Shapiro WB,Corry DB,et al.Cinacalcet HCI and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidisrn in dialysis patients compared with vitamin D alone:the ACHIEVE study results.Clin J Am Soc Nephrol,2008,3(6):1718-1725.
-
9Strippoli GF,Palmer S,Tong A,et al.Meta-analysis of biochemical and patient-level effects of calcimimetic therapy.Am J Kidney Dis,2006,47(5):715-726.
-
10Sprague SM,Evenepoel P,Curzi MP,et al.Simultaneous control of PTH and Ca×P Is sustained over three years of treatment with cinacalcet HC1.Clin J Am Soc Nephrol,2009,4(9):1465-1476.
共引文献221
-
1任燕,金伟民.中药外洗、血液透析、血液透析滤过治疗尿毒症患者皮肤瘙痒的疗效比较[J].中国医师进修杂志,2012,35(S02):63-65. 被引量:1
-
2付晓荣,张燕.血液透析联合血液灌流治疗尿毒症皮肤瘙痒的观察及护理[J].医学信息(医学与计算机应用),2014,0(21):222-222. 被引量:1
-
3叶田增.不同血液净化方式对慢性肾病患者血清甲状旁腺素的影响[J].今日健康,2016,15(1):360-360. 被引量:3
-
4邱维强.肾性骨病诊断与治疗研究进展[J].临床荟萃,2001,16(1):33-34. 被引量:33
-
5谭玥.血透患者口服1,25(OH)_2D_3治疗钙磷代谢紊乱的临床观察[J].中国实用医药,2007,2(31):114-115.
-
6谷禾,陈冬蔚,陈潜琦,金领微,叶白如,徐武敏.高龄维持性血液透析患者的个体化透析管理[J].护理学报,2010,17(2):27-29. 被引量:9
-
7李六生,陈晓芳,李书会,陈飞.组合型人工肾治疗维持性血液透析伴皮肤瘙痒[J].湖北医药学院学报,2012,31(1):59-61. 被引量:2
-
8罗明乾,冼翠华,钟业娟,石晓峰.维持剂量活性vitD3联合组合型人工肾对维持性血液透析患者钙磷代谢紊乱的影响[J].透析与人工器官,2012,23(1):32-34.
-
9朱玮,陈君雪.继发性甲状旁腺功能亢进症的基础与临床研究[J].实用临床医药杂志,2004,8(3):18-21. 被引量:3
-
10王悦,阿拉塔,梁力均,史钧宝,张爱华,朱宁,范敏华.血液透析患者血清铜兰蛋白与钙磷代谢及继发性甲状旁腺功能亢进[J].中国血液净化,2004,3(7):374-376.
同被引文献59
-
1赵琳琳,解汝娟,隋满姝,禹程远,王秦,王德润,姚春影,石芳芳.住院患者慢性肾衰竭的临床特征分析[J].中华临床医师杂志(电子版),2011,5(24):7370-7373. 被引量:9
-
2王成,娄探奇,唐骅,陈珠江,石成钢,尹培达,余学清.常用血液净化方法对维持性血液透析患者血清甲状旁腺素的清除效果[J].中华急诊医学杂志,2005,14(1):61-63. 被引量:108
-
3张波,杨红,范文奎,招敏仪.阿法骨化醇胶丸联合碳酸钙片治疗慢性肾衰继发甲状旁腺功能亢进的疗效观察[J].中国药房,2005,16(14):1086-1088. 被引量:4
-
4郭云珊,袁伟杰,刘明媛,崔若兰.1,25(OH)_2D_3抑制甲状旁腺激素对维持性血液透析患者残余肾功能的影响[J].中国血液净化,2005,4(8):420-423. 被引量:7
-
5苗华,潘明明.慢性肾衰竭继发性甲状旁腺功能亢进的治疗进展[J].国际移植与血液净化杂志,2007,5(1):19-22. 被引量:7
-
6ZOU Qiang,WANG Hong-ying,ZHOU Jian,LAO Zheng-yin,XUE Jun,LI Ming-xin,LI Hai-ming,JIN Yi-ting,GU Yong,ZHANG Yan-ling.Total parathyroidectomy combined with partial autotransplantation for the treatment of secondary hyperparathyroidism[J].Chinese Medical Journal,2007(20):1777-1782. 被引量:22
-
7Brown EM, Gainba G, Riccardi D. et al. Cloning and characterization of an extracellular Ca2 -sensing receptor from bovine parathyroid [ J ]. Na- ture,1993,366(6455) :575 -580.
-
8Wetmore JB, Quarles LD. Caleimimetics or vitamin D analogs for sup- pressing parathyroid hormone in end-stage reinl disease : time for a para- digm shift? [ J]. Nat Clin Pract Nephrol,2009,5:24 -33.
-
9Kuro-o M. Klotho in chronic kidney disease what's new? [ J ]. Nephrol Dial Transplant,2009,24(6) : 1705 - 1708.
-
10Kettder M. Biggar PH. As nature did not predict dialysis-what we can leam from FGF23 in end-stage renal disease? [ J 3. Nephrol Dial Trans- plant ,2009,24(9) :2618 - 2620.
引证文献5
-
1谭焕源.慢性肾功能衰竭继发性甲状旁腺功能亢进的治疗进展[J].中国老年保健医学,2013,11(3):74-76. 被引量:6
-
2陈庆演.益肾活血汤治疗慢性肾衰竭合并甲状旁腺功能亢进80例疗效观察[J].新中医,2015,47(2):63-64. 被引量:5
-
3贾英韬,路丽.甲状旁腺切除术治疗尿毒症患者难治性甲状旁腺功能亢进症30例疗效评价[J].山西医药杂志,2017,46(17):2109-2111. 被引量:3
-
4张谊,刘昌华.继发性甲状旁腺功能亢进症的研究进展[J].河北医药,2022,44(23):3649-3655. 被引量:1
-
5易丽萍,张悦凤.慢性肾脏病患者继发性甲状旁腺功能亢进的发病机制与治疗进展综述[J].中国疗养医学,2019,0(4):386-389. 被引量:6
二级引证文献21
-
1赵双红,吕晶,尹爱萍.慢性肾脏病伴继发性甲状旁腺功能亢进的研究进展[J].中国临床研究,2014,27(6):751-752. 被引量:12
-
2段梦莲,陈创,孙圣荣.50例尿毒症继发性甲状旁腺功能亢进患者的手术疗效分析[J].中国普外基础与临床杂志,2019,26(1):61-66. 被引量:11
-
3王婷,毕伟红.大剂量骨化三醇冲击疗法治疗终末期肾病并发继发性甲状旁腺功能亢进[J].实用临床医药杂志,2014,18(17):29-32. 被引量:6
-
4陈立娟.慢性肾功能衰竭血液透析患者钙磷紊乱的临床观察[J].吉林医学,2015,36(14):3072-3072. 被引量:1
-
5陆建中,陶兰,徐星娥,吴晓芬,王海燕.骨化三醇对慢性肾功能衰竭患者相关指标的影响[J].中国药房,2016,27(15):2056-2058. 被引量:7
-
6郑琪,杨树升,盛国光.中西医结合治疗糖尿病合并慢性肾功能衰竭临床研究[J].中医学报,2016,31(10):1479-1483. 被引量:3
-
7梁亚群,侯文莉,董淼.大剂量骨化三醇冲击疗法对终末期肾病患者并发继发性甲状旁腺功能亢进的疗效[J].中国生化药物杂志,2017,37(1):220-222. 被引量:5
-
8涂小刚.黄芎汤联合双嘧达莫治疗糖尿病合并慢性肾功能衰竭的效果分析[J].临床医学研究与实践,2017,2(29):115-116.
-
9王丽霞.祛瘀泄浊汤加减联合西药治疗慢性肾功能衰竭临床疗效观察[J].新中医,2017,49(12):55-57. 被引量:2
-
10程锦绣,陆继芳,李玥欣,楚德英,王琳琳,刘翠兰,刘圣君,刘华.尿毒清颗粒对腹膜透析患者临床疗效的影响[J].安徽医药,2018,22(10):1997-2000. 被引量:10
-
1吴昌高.胃十二指肠溃疡急性穿孔的诊治现状[J].医学文选,2001,20(S1):83-84.
-
2汪宏,朱丹木.重症急性胰腺炎的诊治现状[J].安徽医学,1998,19(5):74-75.
-
3叶任高,孙川.尿路感染诊治现状[J].中华肾脏病杂志,1993,9(6):359-361. 被引量:15
-
4李佛保.腰椎间盘突出症的诊治现状[J].新医学,1996,27(7):346-347. 被引量:3
-
5沈薇,沈鼎明.重症胰腺炎的诊治现状[J].医师进修杂志,2002,25(6):14-17. 被引量:21
-
6肖开提,买买提力,王喜艳.重症急性胰腺炎诊治现状[J].中华今日医学杂志,2003,3(8):87-89.
-
7植泉业.急性胰腺炎的诊治现状[J].海南医学,2009,20(S2):240-242.
-
8王旭东,王蕊.重症急性胰腺炎(SAP)诊治现状[J].医学信息(医学与计算机应用),2001,14(12):890-892.
-
9刘爱红,王莹.高PTH血症对CRF心血管病的影响及治疗[J].山西职工医学院学报,2010,20(2):86-88. 被引量:1
-
10朱化强,代文杰.腹茧症的外科诊治现状[J].中国普通外科杂志,2007,16(4):375-377. 被引量:31